Role of acupuncture in the treatment of migraine

Expert Review of Neurotherapeutics

Volumn 7, Issue 9, 2007, Pages 1121-1134

  Endres, Heinz G ^a   Diener, Hans Christoph ^b   Molsberger, Albrecht ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c Centre for Clinical Acupuncture and Research   (Germany)

Author keywords

Acupuncture; Headache; Migraine; Pain

Indexed keywords

FLUNARIZINE; METOPROLOL; NORADRENALIN; SEROTONIN; SUMATRIPTAN;

ACUPUNCTURE; CHINESE MEDICINE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HEADACHE; HUMAN; MIGRAINE; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACUPUNCTURE THERAPY; CLINICAL TRIALS; EVIDENCE-BASED MEDICINE; HUMANS; MIGRAINE DISORDERS; TREATMENT OUTCOME;

EID: 34548858711     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.9.1121     Document Type: Review

References (72)

1. Burke A, Upchurch DM, Dye C, Chyu L. Acupuncture use in the United States: findings from the National Health Interview Survey. J. Altern. Complement. Med. 12(7), 639-648 (2006).
2. Endres HG, Diener HC, Maier C, Böwing G, Trampisch HJ, Zenz M. Acupuncture for the treatment of chronic headaches. Dtsch. Arztebl. 104(3), A114-A122 (2007).
3. Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14(2), 97-106 (1994).
4. Rasmussen BK. Epidemiology of headache. Cephalalgia 21(7), 774-777 (2001).
5. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA 279(5), 381-383 (1998).
6. Silberstein SD. Preventive treatment of headaches. Curr. Opin. Neurol. 18(3), 289-292 (2005).
7. Limmroth V, Diener HC. Neues zu pathophysiologie und therapie der migräne. Notfallmedizin (1,2), 32-41 (2003).
8. Olesen J, Bousser MG, Diener H et al. The International Classification of Headache Disorders (2nd Edition). Cephalalgia 24(Suppl. 1), 1-160 (2004).
9. Ernst E. Acupuncture - a critical analysis. J. Intern. Med. 259(2), 125-137 (2006). • Good general overview of acupuncture, beginning with its history and covering historical and contemporary concepts of its mechanisms of action, clinical trials and the data on safety of acupuncture.
10. No authors listed. NIH Consensus Conference. Acupuncture. JAMA 280(17), 1518-1524 (1998).
11. Limmroth V, Katsarava Z, Liedert B et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain 92(1,2), 101-106 (2001).
12. Weiller C, May A, Limmroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat. Med. 1(7), 658-660 (1995).
13. Uddman R, Edvinsson L. Neuropeptides in the cerebral circulation. Cerebrovasc. Brain Metab. Rev. 1(3), 230-252 (1989).
14. Hanko J, Hardebo JE, Kahrstrom J, Owman C, Sundler F. Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries. Neurosci. Lett. 57(1), 91-95 (1985).
15. Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev. 5(3), 159-177 (1993).
16. Bahra A, Matharu MS, Büchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 357, 1016-1017 (2001).
17. Melzack R, Wall PD. Pain mechanisms: a new theory. Science 150(699), 971-979 (1965).
18. Carlsson C. Acupuncture mechanisms for clinically relevant long-term effects - reconsideration and a hypothesis. Acupunct. Med. 20(2-3), 82-99 (2002). • Good and very extensive overview of possible mechanisms of action of acupuncture.
19. Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain 118(1-2), 215-223 (2005).
20. Rossi P, Serrao M, Perrotta A, Pierelli F, Sandrini G, Nappi G. Neurophysiological approach to central pain modulation in primary headaches. J. Headache Pain 6(4), 191-194 (2005).
21. Diener HC, Kronfeld K, Boewing G et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol. 5(4), 310-316 (2006).
22. Bingel U, Schoell E, Buchel C. Imaging pain modulation in health and disease. Curr. Opin. Neurol. 20(4), 424-431 (2007). •• Very good review of the possible mechanisms of pain modulation in the CNS based on the results of imaging techniques (e.g., fMRI or PET).
23. Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 295(5560), 1737-1740 (2002). •• PET study postulating a common neuronal network for placebo and opioid analgesia.
24. Kong J, Gollub RL, Rosman IS et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci. 26(2), 381-388 (2006). • fMRI study on the effects of placebo acupuncture demonstrating detectable placebo analgesia after expectancy manipulation.
25. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J. Neurosci. 25(45), 10390-10402 (2005). •• Very good overview of the functional neuroanatomy of placebo analgesia.
26. Cheng R, Pomeranz B, Yu G. Dexamethasone partially reduces and 2% saline-treatment abolished electroacupunture analgesia: these findings implicate pituitary endorphins. Life Sci. 24(16), 1481-1486 (1979).
27. Pomeranz B, Cheng R, Law P. Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Exp. Neurol. 54(1), 172-178 (1977).
28. Takeshige C, Kobori M, Hishida F, Luo CP, Usami S. Analgesia inhibitory system involvement in nonacupuncture pointstimulation-produced analgesia. Brain Res. Bull. 28(3), 379-391 (1992).
29. Sato T, Usami S, Takeshige C. Role of the arcuate nucleus of the hypothalamus as the descending pain-inhibitory system in acupuncture point and non-point produced analgesia. In: Studies on the Mechanism of Acupuncture Anagesia Based on Animal Experiments. Takeshige C (Ed.). Showa University Press, Tokyo, Japan 542 (1986).
30. Wang Q, Mao L, Han J. The arcuate nucleus of hypothalamus mediates low but not high frequency electroacupuncture analgesia in rats. Brain Res. 513(1), 60-66 (1990).
31. Takeshige C, Zhao WH, Guo SY. Convergence from the preoptic area and arcuate nucleus to the median eminence in acupuncture and nonacupuncture point stimulation analgesia. Brain Res. Bull. 26(5), 771-778 (1991).
32. Takeshige C, Oka K, Mizuno T et al. The acupuncture point and its connecting central pathway for producing acupuncture analgesia. Brain Res. Bull. 30(1-2), 53-67 (1993).
33. Wang QA, Mao LM, Han JS. The role of periaqueductal gray in mediation of analgesia produced by different frequencies electroacupuncture stimulation in rats. Int. J. Neurosci. 53(2-4), 167-172 (1990).
34. McLennan H, Gilfillan K, Heap Y. Some pharmacological observations on the analgesia induced by acupuncture in rabbits. Pain 3(3), 229-238 (1977).
35. Shen E, Ma WH, Lan C. Involvement of descending inhibition in the effect of acupuncture on the splanchnically evoked potential in the orbital cortex of cat. Sci. Sin. 21(5), 677-685 (1978).
36. Cheng RS, Pomeranz B. Monoaminergic mechanism of electroacupuncture analgesia. Brain Res. 215(1,2), 77-92 (1981).
37. Han CS, Chou PH, Lu CC, Lu LH, Yang TH, Jen MF. The role of central 5-hydroxytryptamine in acupuncture analgesia. Sci. Sin. 22(1), 91-104 (1979).
38. Lao L, Zhang RX, Zhang G, Wang X, Berman BM, Ren K. A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats. Brain Res. 1020(1,2), 18-29 (2004).
39. Janson W, Stein C. Peripheral opioid analgesia. Curr. Pharm. Biotechnol. 4(4), 270-274 (2003).
40. Stein C, Machelska H, Schafer M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 60(6), 416-424 (2001).
41. Ceccherelli F, Gagliardi G, Ruzzante L, Giron G. Acupuncture modulation of capsaicin-induced inflammation: effect of intraperitoneal and local administration of naloxone in rats. A blinded controlled study. J. Altern. Complement. Med. 8(3), 341-349 (2002).
42. Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann. Int. Med. 136(6), 471-476 (2002).
43. Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann. Int. Med. 136(11), 817-825 (2002). • Thoughtful essay on the various levels of the patient-physician relationship, with special attention to the healing ritual associated with alternative medicine, which leads to an augmented placebo effect that can be superior to a placebo pill.
44. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J. Clin. Epidemiol. 53(8), 786-792 (2000).
45. Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J. Neurosci. 26(44), 11501-11509 (2006).
46. Ploghaus A, Narain C, Beckmann CF et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J. Neurosci. 21(24), 9896-9903 (2001).
47. Linde K, Streng A, Jurgens S et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA 293(17), 2118-2125 (2005).
48. Linde K, Witt CM, Streng A et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128(3), 264-271 (2007). • Using pooled data from four recent randomized controlled trials, the authors elegantly demonstrate the influence of patient expectations on acupuncture outcomes; patients with high expectations were more likely to report better outcomes.
49. Wager TD, Rilling JK, Smith EE et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303(5661), 1162-1167 (2004). • Two fMRI studies that provide sound insights into the neural mechanisms underlying placebo analgesia, the decrease of neural responses in pain-sensitive brain regions and the representation of expectations for pain relief within regions of the prefrontal cortex that modulate activity in pain-responsive regions.
50. Scharf H-P, Mansmann U, Streitberger K et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann. Intern. Med. 145(1), 12-20 (2006).
51. Pomeranz B, Berman B. Wissenschaftliche Grundlagen der Akupunktur. In: Akupunktur, Lehrbuch und Atlas. Stux G, Stiller N, Berman B, Pomeranz B (Eds). Springer, Berlin, Germany 7-63 (2003).
52. Irnich D, Beyer A. Neurobiological mechanisms of acupuncture analgesia. Schmerz 16(2), 93-102 (2002).
53. Vickers AJ, Rees RW, Zollman CE et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. Br. Med. J. 328(7442), 744-749 (2004).
54. Ernst E, White A. Acupuncture: safety first. Br. Med. J. 314(7091), 1362 (1997).
55. Vincent C. The safety of acupuncture. Br. Med. J. 323(7311), 467-468 (2001).
56. Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache. Cochrane Database Syst. Rev. 1, CD001218 (2001). • The latest Cochrane review of acupuncture for headache, including migraine.
57. Diener H, Limmroth V. Prevention of migraine: β-blockers and amine agonists: efficacy. In: Preventive Pharmacotherapy of Headache Disorders. Olesen J, Silberstein S, Tfelt-Hansen P (Eds). Oxford University Press, Oxford, UK 59-66 (2004).
58. Melchart D, Hager S, Hager U, Liao J, Weidenhammer W, Linde K. Treatment of patients with chronic headaches in a hospital for traditional Chinese medicine in Germany. A randomised, waiting list controlled trial. Complement. Ther. Med. 12(2-3), 71-78 (2004).
59. ICD-10 Guide for Headaches. International Headache Classification Committee. Cephalalgia 17(Suppl. 19), 1-82 (1997).
60. Linde M, Fjell A, Carlsson J, Dahlof C. Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. Cephalalgia 25(1), 41-47 (2005).
61. Allais G, De Lorenzo C, Quirico PE et al. Non-pharmacological approaches to chronic headaches: transcutaneous electrical nerve stimulation, laser therapy and acupuncture in transformed migraine treatment. Neurol. Sci. 24(Suppl. 2), S138-S142 (2003).
62. Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J. Intern. Med. 253(2), 181-188 (2003).
63. Streng A, Linde K, Hoppe A et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache 46(10), 1492-1502 (2006).
64. Alecrim-Andrade J, Maciel-Junior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia 26(5), 520-529 (2006).
65. Allais G, De Lorenzo C, Quirico PE et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache 42(9), 855-861 (2002).
66. Tfelt-Hansen P, Block G, Dahlof C et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 20(9), 765-786 (2000). •• Clearly organized guidelines for conducting drug trials for migraine, divided into drug trials dealing with acute treatment and those dealing with prophylactic treatment, and including all aspects of various trial designs.
67. Diener HC. Headache. Curr. Opin. Neurol. 18(3), 279-282 (2005).
68. Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Chronic migraine is an earlier stage of transformed migraine in adults. Neurology 65(10), 1556-1561 (2005).
69. Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders (2nd edition). Cephalalgia 24(Suppl. 1), 9-160 (2004).
70. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7), 1-93 (1988).
71. Göbel H. Classification of headache: criteria and practical implementation. Z. Arztl. Fortbild. 87(6), 451-458 (1993).
72. Deutsches Ärzteblatt www.aerzteblatt.de/v4/archiv/english.asp?q= 1&y=2007